Skip to main content
Table of Contents
Print

Can Cannabis Support PTSD Patients During Group Therapy? 

Author: Dr. Clarissa Morton, PharmD

The use of cannabis in group therapy for PTSD is a subject of growing interest. Group sessions rely on trust, openness, and the ability to share experiences, yet many patients struggle with anxiety or fear of judgement. Cannabis may, in some cases, help reduce barriers by easing stress and encouraging participation. 

Therapists often highlight the value of peer support in trauma, where connecting with others who have lived similar experiences can improve recovery outcomes. Cannabis may help patients engage in this process more comfortably, though its role is complex and not universally positive. 

How Cannabis May Influence Group Therapy 

The effects of cannabis on group therapy vary widely depending on dosage, strain, and patient sensitivity. Below are some areas where it may influence outcomes. 

Reducing Social Anxiety 

For some, cannabis can lower the intensity of nerves before speaking in front of others. This social anxiety relief may make it easier to share personal experiences during sessions. 

Encouraging Participation 

A sense of calm or relaxation can help patients feel more present and willing to engage. This connection may improve therapy participation, particularly in the early stages of group work. 

Risks of Overuse 

However, excessive use may blunt emotions or reduce focus, limiting the benefits of cannabis in group therapy for PTSD. Careful monitoring is essential. 

Although more research is needed, some patients find cannabis helps them feel less isolated and more connected. For many, cannabis in group therapy for PTSD highlights both opportunities and challenges that require professional oversight. 

Visit providers like LeafEase for personalised consultations that explore safe and supportive approaches to cannabis use in therapy settings. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Post-Traumatic Stress Disorder (PTSD). 

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories